Clinical Trials Logo

Filter by:
NCT ID: NCT02902445 Completed - Gastroenteritis Clinical Trials

Glycan Attachment Specificity, Toward ROtavirus Vaccine IMprovement GASTROVIMc (Clinical Investigation)

Gastrovimc
Start date: February 28, 2017
Phase:
Study type: Observational

The GASTROVIM research explores the links between individual genetic susceptibility, genetic variability of rotavirus strains and effectiveness of immunization with the rotavirus vaccination: a clinical investigation to assess glycan attachment specificity, toward rotavirus vaccine improvement.

NCT ID: NCT02902263 Completed - Ischemic Stroke Clinical Trials

Inter-Hospital Transfer to a Vascular Neurology Unit After Telethrombolysis

TRATT
Start date: January 2014
Phase:
Study type: Observational

Early thrombolysis is essential in treating ischemic strokes. The time window for thrombolysis is limited to 4,5 hours after symptoms onset. In the French region of Franche Comté, in order to reduce the thrombolytic delay, a telemedicine network was developed between the neurovascular reference unit (NVU) localised in the University Hospital of Besançon and the peripheral hospital centres. Patients may then be transported to the NVU immediately after the thrombolysis initiation. The aim of our study was to assess the relevance of a systematic medicalization of transfer to the NVU of patients with stroke who were telethrombolyzed before. It was a retrospective, monocentric and observational study conducted over 24 months, in Franche-Comte (France).

NCT ID: NCT02902029 Completed - Malignant Melanoma Clinical Trials

Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma

ImmunoCobiVem
Start date: November 2016
Phase: Phase 2
Study type: Interventional

Most patients with locally advanced or metastatic tumors succumb to their disease. Thus, there is a substantial need for novel therapeutic strategies to improve the outcome for patients with advanced or metastatic melanoma. Targeting the the Ras/Raf signalling pathway by BRAF and MEK inhibition as well as targeting immunologic checkpoint control with an antiPD-L1 antibody have emerged as treatment option. In this study the best timing for sequential use of both treatment options (BRAF/MEK inhibition and antiPD-L1 antibody) in patients with unresectable or metastatic BRAFV600 mutant melanoma will be assessed.

NCT ID: NCT02902016 Completed - Lactose Intolerance Clinical Trials

Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies

Start date: July 16, 2015
Phase: N/A
Study type: Interventional

This study is designed to assess the effect of a new PPARgamma modulator on the expression and activity of the lactase enzyme in human intestinal epithelial cells. Based on their previous experimental results, the investigators hypothesized that modulating intestinal PPARgamma activity is a new pharmacological mechanism allowing the control of lactase expression and activity in the gut

NCT ID: NCT02901795 Completed - Clinical trials for Fetal Membranes, Premature Rupture

Early Detection of Chorioamnionitis in Preterm Premature Rupture of Membranes

AiRPM
Start date: November 2, 2018
Phase:
Study type: Observational

All included patients will have their fetal heart rate recording performed with an EDAN F3 fetal monitor that allowed the back up recording of the fetal heart rate beat to beat detection. Fetal heart rate variability analysis will be performed using Matalb® software.

NCT ID: NCT02901509 Completed - Quality of Life Clinical Trials

Impact of the Chikungunya Outbreak in Reunion Island on the Quality of Life After 10 Years

QoLCHIK
Start date: June 2016
Phase:
Study type: Observational

QoLCHIK study aims at evaluating impact of chikungunya infection on the quality of life of infected people during the 2005-2006 outbreak in Reunion Island and followed in the TELECHIK cohort by comparing scores of SF-36 health survey.

NCT ID: NCT02901470 Completed - Pressure Ulcer Clinical Trials

Observational Study of the Incidence of Pressure Ulcers on the Help Support of Prevention of Bedsores POLYAIR®

Start date: February 11, 2015
Phase:
Study type: Observational

The support of help to the prevention of sores include a big diversity of devices. The clinical experiment of these support comes up against the problem of the large number of factors participants in the genesis of bedsores. Nevertheless, it seems to be interesting to estimate the incidence of bedsores in these supports, with control of other factors

NCT ID: NCT02901015 Completed - Schizophrenia Clinical Trials

Evaluation and Validation of Social Cognition Battery to Characterize Schizophrenic Patients Functioning

EVACO
Start date: April 2013
Phase: N/A
Study type: Interventional

Interventional, multicenter, and longitudinal study, of a cohort of patients with schizophrenia, evaluated on social cognition, neurocognition, symptoms, functioning with 12 months interval.

NCT ID: NCT02901002 Completed - Clinical trials for Complex Regional Pain Syndromes

Body Perception and Complex Regional Pain Syndrome

SDRC
Start date: January 6, 2017
Phase: N/A
Study type: Observational

In CRPS, perturbation of body image and pseudo-neglect syndrome of the body part affected are frequently found. Pain and sensory perturbation seems to modify the way patients perceived their body part affected. Does a local body image perturbation can affect the balanced of the global self-awareness?

NCT ID: NCT02900989 Completed - Suicidal Ideation Clinical Trials

Validation of the French Version of Ask Suicide-Screening Questions (ASQ) in Adolescents Managed in Pediatric Emergency Unit

ASQ-Fr
Start date: July 2016
Phase: N/A
Study type: Interventional

The ASQ-Fr study aims at validating the French version of Ask Suicide-Screening Questions composed of 5 items in adolescents managed in pediatric emergency department. Therefore, use of this brief valid screening instrument could assess the risk for suicide in pediatric patients and then improve the prevention of suicidal tendencies in this population.